Practice
Featured experience
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
J.F. Lehman closes $2.2 billion Fund VI
We advised J.F. Lehman on the fundraise and related matters
GHK Capital Partners completes $870 million fundraise for its second fund
We advised GHK Capital Partners on the fundraise and related matters for GHK Fund II
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Revolution Medicines $300 million follow-on offering
We advised the underwriters in connection with the equity offering
Uniti $1.11 billion notes offering and tender offer and consent solicitation
We advised Uniti on the high-yield notes offering, concurrent tender offer and related consent solicitation
SVB Financial $1.25 billion senior notes and perpetual preferred stock offerings
We advised the underwriters on the concurrent investment-grade debt and depositary shares offerings
Vinci Partners Investments $250 million IPO
We advised Vinci Partners on its IPO and Nasdaq listing
Patria Investments $588.4 million IPO
We advised Patria on its IPO and Nasdaq listing
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering
Morgan Stanley $7.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Perion Network $66 million follow-on offering
We advised Perion, whose shares are listed on Nasdaq and the Tel Aviv Stock Exchange
CrowdStrike Holdings $750 million bond offering
We advised CrowdStrike on the SEC-registered offering
Provident Acquisition $230 million IPO
We advised Provident, a SPAC, on its IPO and Nasdaq listing